Polpharma Biologics Email Format
Biotechnology ResearchZug, Switzerland201-500 Employees
Polpharma Biologics is a biopharmaceutical company that develops, manufactures, and commercializes biosimilars for global markets. It oversees the full value chain—from program selection and resource allocation to development execution and asset monetization—to move ideas toward launch. An international team provides expertise in program leadership, regulatory strategy, clinical oversight, CMC integration, device development, and quality, working with contract development and manufacturing organizations to deliver end-to-end biosimilars—from cell line to finished product—across multiple therapeutic areas, with medicines brought to patients worldwide by commercial partners. The company is headquartered in Zug, Switzerland, and operates in the biotechnology research sector with a mid-sized workforce. In May 2026, Polpharma Biologics announced a licensing agreement with Argentina-based Tuteur, reflecting ongoing expansion of its international partnerships.